BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 32163832)

  • 1. Housing condition-associated changes in gut microbiota further affect the host response to diet-induced nonalcoholic fatty liver.
    Chen YH; Wang YC; Chiu CC; Lee YP; Hung SW; Huang CC; Chiu CF; Chen TH; Huang WC; Chuang HL
    J Nutr Biochem; 2020 May; 79():108362. PubMed ID: 32163832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis.
    Chiu CC; Ching YH; Li YP; Liu JY; Huang YT; Huang YW; Yang SS; Huang WC; Chuang HL
    Nutrients; 2017 Nov; 9(11):. PubMed ID: 29113135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gnotobiotic mice inoculated with Firmicutes, but not Bacteroidetes, deteriorate nonalcoholic fatty liver disease severity by modulating hepatic lipid metabolism.
    Chen YH; Chiu CC; Hung SW; Huang WC; Lee YP; Liu JY; Huang YT; Chen TH; Chuang HL
    Nutr Res; 2019 Sep; 69():20-29. PubMed ID: 31470288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.
    Wang P; Wang J; Li D; Ke W; Chen F; Hu X
    J Nutr Biochem; 2020 Jul; 81():108363. PubMed ID: 32388250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of different diets on intestinal microbiota and nonalcoholic fatty liver disease development.
    Liu JP; Zou WL; Chen SJ; Wei HY; Yin YN; Zou YY; Lu FG
    World J Gastroenterol; 2016 Aug; 22(32):7353-64. PubMed ID: 27621581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier.
    Zhou D; Pan Q; Xin FZ; Zhang RN; He CX; Chen GY; Liu C; Chen YW; Fan JG
    World J Gastroenterol; 2017 Jan; 23(1):60-75. PubMed ID: 28104981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.
    Matsui M; Fukunishi S; Nakano T; Ueno T; Higuchi K; Asai A
    mBio; 2021 Aug; 12(4):e0115521. PubMed ID: 34225483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red pitaya betacyanins protects from diet-induced obesity, liver steatosis and insulin resistance in association with modulation of gut microbiota in mice.
    Song H; Chu Q; Yan F; Yang Y; Han W; Zheng X
    J Gastroenterol Hepatol; 2016 Aug; 31(8):1462-9. PubMed ID: 26699443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astragalus mongholicus polysaccharides ameliorate hepatic lipid accumulation and inflammation as well as modulate gut microbiota in NAFLD rats.
    Zhong M; Yan Y; Yuan H; A R; Xu G; Cai F; Yang Y; Wang Y; Zhang W
    Food Funct; 2022 Jul; 13(13):7287-7301. PubMed ID: 35726797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of Gut Microbiota by
    Wu S; Hu R; Nakano H; Chen K; Liu M; He X; Zhang H; He J; Hou DX
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30563142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chicoric Acid Ameliorates Nonalcoholic Fatty Liver Disease via the AMPK/Nrf2/NF
    Ding X; Jian T; Li J; Lv H; Tong B; Li J; Meng X; Ren B; Chen J
    Oxid Med Cell Longev; 2020; 2020():9734560. PubMed ID: 33204402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnane X receptor exacerbates nonalcoholic fatty liver disease accompanied by obesity- and inflammation-prone gut microbiome signature.
    Kim S; Choi S; Dutta M; Asubonteng JO; Polunas M; Goedken M; Gonzalez FJ; Cui JY; Gyamfi MA
    Biochem Pharmacol; 2021 Nov; 193():114698. PubMed ID: 34303710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of the Caspases 1/11 Modulates Liver Global Lipid Profile and Gut Microbiota in High-Fat-Diet-Induced Obese Mice.
    de Sant'Ana LP; Ribeiro DJS; Martins AMA; Dos Santos FN; Corrêa R; Almeida RDN; Eberlin MN; Maurice CF; Magalhães KG
    Front Immunol; 2019; 10():2926. PubMed ID: 31998283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axis.
    Vitaglione P; Mazzone G; Lembo V; D'Argenio G; Rossi A; Guido M; Savoia M; Salomone F; Mennella I; De Filippis F; Ercolini D; Caporaso N; Morisco F
    J Nutr Sci; 2019; 8():e15. PubMed ID: 31037218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatobiliary and pancreatic: Multi-donor fecal microbiota transplantation attenuated high-fat diet-induced hepatic steatosis in mice by remodeling the gut microbiota.
    Shou D; Luo Q; Tang W; Cao C; Huang H; Chen H; Zhou Y
    J Gastroenterol Hepatol; 2023 Dec; 38(12):2195-2205. PubMed ID: 37787118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triclosan targeting of gut microbiome ameliorates hepatic steatosis in high fat diet-fed mice.
    Sun D; Zuo C; Huang W; Wang J; Zhang Z
    J Antibiot (Tokyo); 2022 Jun; 75(6):341-353. PubMed ID: 35440769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desulfovibrio vulgaris, a potent acetic acid-producing bacterium, attenuates nonalcoholic fatty liver disease in mice.
    Hong Y; Sheng L; Zhong J; Tao X; Zhu W; Ma J; Yan J; Zhao A; Zheng X; Wu G; Li B; Han B; Ding K; Zheng N; Jia W; Li H
    Gut Microbes; 2021; 13(1):1-20. PubMed ID: 34125646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liraglutide Attenuates Nonalcoholic Fatty Liver Disease by Modulating Gut Microbiota in Rats Administered a High-Fat Diet.
    Zhang N; Tao J; Gao L; Bi Y; Li P; Wang H; Zhu D; Feng W
    Biomed Res Int; 2020; 2020():2947549. PubMed ID: 32149099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phytic Acid Improves Hepatic Steatosis, Inflammation, and Oxidative Stress in High-Fat Diet (HFD)-Fed Mice by Modulating the Gut-Liver Axis.
    Ran X; Hu G; He F; Li K; Li F; Xu D; Liu J; Fu S
    J Agric Food Chem; 2022 Sep; 70(36):11401-11411. PubMed ID: 36040330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.